These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37779628)

  • 1. Low-intensity focused ultrasound targeting the nucleus accumbens as a potential treatment for substance use disorder: safety and feasibility clinical trial.
    Mahoney JJ; Haut MW; Carpenter J; Ranjan M; Thompson-Lake DGY; Marton JL; Zheng W; Berry JH; Tirumalai P; Mears A; D'Haese P; Finomore VS; Hodder SL; Rezai AR
    Front Psychiatry; 2023; 14():1211566. PubMed ID: 37779628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder.
    Rezai AR; Mahoney JJ; Ranjan M; Haut MW; Zheng W; Lander LR; Berry JH; Farmer DL; Marton JL; Tirumalai P; Mears A; Thompson-Lake DGY; Finomore VS; D'Haese PF; Aklin WM; George DT; Corrigan JD; Hodder SL
    J Neurosurg; 2024 Jan; 140(1):231-239. PubMed ID: 37329519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report illustrating the effects of repetitive transcranial magnetic stimulation on cue-induced craving in an individual with opioid and cocaine use disorder.
    Mahoney JJ; Marshalek PJ; Rezai AR; Lander LR; Berry JH; Haut MW
    Exp Clin Psychopharmacol; 2020 Feb; 28(1):1-5. PubMed ID: 31647279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Transcranial Focused Ultrasound Stimulation of Nucleus Accumbens on Neuronal Gene Expression and Brain Tissue in High Alcohol-Preferring Rats.
    Deveci E; Akbaş F; Ergun AŞ; Kurtulmuş A; Koçak AB; Boyraz RK; Tok OE; Aydın MŞ; Kılıç Ö; Bozkurt A; Uysal Ö; Eşrefoğlu M; Koçyiğit A; Öztürk A; Lawrence AJ; Kırpınar I
    Mol Neurobiol; 2023 Feb; 60(2):1099-1116. PubMed ID: 36417101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids).
    Shmulewitz D; Stohl M; Greenstein E; Roncone S; Walsh C; Aharonovich E; Wall MM; Hasin DS
    Psychol Med; 2023 Apr; 53(5):1955-1969. PubMed ID: 35506791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder.
    Mahoney JJ; Haut MW; Hodder SL; Zheng W; Lander LR; Berry JH; Farmer DL; Marton JL; Ranjan M; Brandmeir NJ; Finomore VS; Hensley JL; Aklin WM; Wang GJ; Tomasi D; Shokri-Kojori E; Rezai AR
    Exp Clin Psychopharmacol; 2021 Apr; 29(2):210-215. PubMed ID: 34043402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incubation of Cue-Induced Craving in Adults Addicted to Cocaine Measured by Electroencephalography.
    Parvaz MA; Moeller SJ; Goldstein RZ
    JAMA Psychiatry; 2016 Nov; 73(11):1127-1134. PubMed ID: 27603142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the effect of low-intensity focused ultrasound on postpartum uterine involution and breast pain in puerperal women: a randomised controlled trial.
    Wei D; Yue J; Meng J; Gao J; Yang L; Niu X; Wang Z
    Sci Rep; 2024 Jan; 14(1):658. PubMed ID: 38182657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review.
    Kedzior KK; Gerkensmeier I; Schuchinsky M
    BMC Psychiatry; 2018 May; 18(1):137. PubMed ID: 29776355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.
    Freet CS; Evans B; Brick TR; Deneke E; Wasserman EJ; Ballard SM; Stankoski DM; Kong L; Raja-Khan N; Nyland JE; Arnold AC; Krishnamurthy VB; Fernandez-Mendoza J; Cleveland HH; Scioli AD; Molchanow A; Messner AE; Ayaz H; Grigson PS; Bunce SC
    Addict Sci Clin Pract; 2024 Jul; 19(1):56. PubMed ID: 39061093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Music therapy for people with substance use disorders.
    Ghetti C; Chen XJ; Brenner AK; Hakvoort LG; Lien L; Fachner J; Gold C
    Cochrane Database Syst Rev; 2022 May; 5(5):CD012576. PubMed ID: 35532044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of opioid-stimulant co-use on tonic and cue-induced craving.
    Hochheimer M; Strickland JC; Rabinowitz JA; Ellis JD; Bergeria CL; Hobelmann JG; Huhn AS
    J Psychiatr Res; 2023 Aug; 164():15-22. PubMed ID: 37301033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The centrality of craving in network analysis of five substance use disorders.
    Gauld C; Baillet E; Micoulaud-Franchi JA; Kervran C; Serre F; Auriacombe M
    Drug Alcohol Depend; 2023 Apr; 245():109828. PubMed ID: 36868091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study.
    Prochaska JJ; Vogel EA; Chieng A; Kendra M; Baiocchi M; Pajarito S; Robinson A
    J Med Internet Res; 2021 Mar; 23(3):e24850. PubMed ID: 33755028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.
    Duailibi MS; Cordeiro Q; Brietzke E; Ribeiro M; LaRowe S; Berk M; Trevizol AP
    Am J Addict; 2017 Oct; 26(7):660-666. PubMed ID: 28898494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Intensity Ultrasound Modulation May Prevent Myocardial Infarction-induced Sympathetic Neural Activation and Ventricular Arrhythmia.
    Wang S; Li B; Li X; Wu L; Zhu T; Zhao D; Jiang H
    J Cardiovasc Pharmacol; 2020 May; 75(5):432-438. PubMed ID: 32079857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
    Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
    Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focused Ultrasound Modulates Dopamine in a Mesolimbic Reward Circuit.
    Olaitan GO; Ganesana M; Strohman A; Lynch WJ; Legon W; Jill Venton B
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of improved behavioral inhibition on decreased cue-induced craving in heroin use disorder: A preliminary intermittent theta burst stimulation study.
    Kang T; Ding X; Zhao J; Li X; Xie R; Jiang H; He L; Hu Y; Liang J; Zhou G; Huo X
    J Psychiatr Res; 2022 Aug; 152():375-383. PubMed ID: 35797913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.